“Comparison of anti-thrombotic strategies using Bivalirudin, Heparin plus Eptifibatide, and Unfractionated Heparin Monotherapy for acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI): A single-center observational stu”, Univ. Heart J., vol. 17, no. 2, pp. 91–98, Jun. 2021, doi: 10.3329/uhj.v17i2.54364.